General InformationBioAge Labs is a California-based epigenetic aging biotech company founded in 2018 with approximately 20-30 employees that develops biological age measurement and reversal technologies.
Funding & FinancialsThe company has raised approximately $20-25 million across multiple rounds, with Series B funding from notable longevity and venture investors.
Leadership & TeamFounded by Kristen Fortney (CEO), a computational biologist and longevity researcher with expertise in aging biology and biomarker development.
Recent ActivityRecent developments include expanding their epigenetic clock applications for clinical use and partnerships with pharmaceutical companies for drug development and aging research.